Perceptive Advisors’s Solid Biosciences SLDB Stock Holding History

Perceptive Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85.7M	Buy	11,906,646 +73,107	+0.6%	+$470K	1.68%	19
2025 Q4	$66.7M	Hold	11,833,539	–	–	1.19%	28
2025 Q3	$73M	Sell	11,833,539 -73,107	-0.6%	-$427K	2.11%	16
2025 Q2	$58M	Hold	11,906,646	–	–	2.15%	11
2025 Q1	$44.1M	Buy	11,906,646 +5,000,000	+72%	+$21.4M	1.56%	15
2024 Q4	$27.6M	Hold	6,906,646	–	–	0.76%	36
2024 Q3	$48.1M	Hold	6,906,646	–	–	1.02%	31
2024 Q2	$39.2M	Hold	6,906,646	–	–	0.94%	27
2024 Q1	$92M	Buy	6,906,646 +3,410,713	+98%	+$31.9M	1.61%	19
2023 Q4	$21.5M	Hold	3,495,933	–	–	0.48%	51
2023 Q3	$8.81M	Hold	3,495,933	–	–	0.29%	61
2023 Q2	$18.3M	Hold	3,495,933	–	–	0.53%	52
2023 Q1	$16.6M	Hold	3,495,933	–	–	0.49%	48
2022 Q4	$18.8M	Buy	3,495,933 +2,601,763	+291%	+$17.1M	0.53%	46
2022 Q3	$6.26M	Hold	894,170	–	–	0.18%	76
2022 Q2	$8.26M	Hold	894,170	–	–	0.26%	67
2022 Q1	$16.1M	Hold	894,170	–	–	0.32%	64
2021 Q4	$23.5M	Hold	894,170	–	–	0.36%	64
2021 Q3	$32.1M	Hold	894,170	–	–	0.47%	54
2021 Q2	$49.1M	Hold	894,170	–	–	0.64%	42
2021 Q1	$74.2M	Buy	894,170 +173,913	+24%	+$19.2M	0.94%	28
2020 Q4	$81.9M	Buy	720,257 +270,270	+60%	+$17.1M	0.88%	33
2020 Q3	$13.7M	Hold	449,987	–	–	0.2%	77
2020 Q2	$19.8M	Buy	+449,987	New	+$18.7M	0.32%	62
2019 Q4	–	Sell	-449,987	Closed	-$69.8M	–	122
2019 Q3	$69.8M	Buy	449,987 +188,172	+72%	+$21.3M	1.88%	14
2019 Q2	$22.6M	Buy	+261,815	New	+$28.6M	0.52%	45
2019 Q1	–	Sell	-261,815	Closed	-$105M	–	118
2018 Q4	$105M	Buy	+261,815	New	+$123M	4.01%	6

Other funds holding SLDB

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors's SLDB Position: Q1 2026 in Review

Perceptive Advisors increased its Solid Biosciences (SLDB) stake by 0.62% in Q1 2026, buying an estimated $470K and bringing the position to 11,906,646 shares worth $85.7M. The position accounts for 1.68% of the portfolio, ranked #19.

Perceptive Advisors first reported a position in SLDB in Q4 2018 and has held it in 27 quarters since. The position peaked at $105M in Q4 2018. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

Perceptive Advisors held 11,906,646 shares of Solid Biosciences worth $85.7M as of Q1 2026.
Perceptive Advisors bought 73,107 Solid Biosciences shares in Q1 2026, an estimated $470K.
Solid Biosciences made up 1.68% of Perceptive Advisors's portfolio in Q1 2026, its #19 holding.
Perceptive Advisors first reported a position in Solid Biosciences in Q4 2018 and has held it in 27 quarters since.
Perceptive Advisors's Solid Biosciences position peaked at $105M in Q4 2018.
150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.